SCHEMBL7967862

SCHEMBL7967862

CC1(C)Oc2c(cccc2C(=O)O)NC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
BRD4 O60885 3/20 0.37
LIG1 P18858 1/20 0.37
MAPT P10636 2/20 0.36
CREBBP Q92793 2/20 0.36
DRD2 P14416 1/20 0.35
ALOX15 P16050 2/20 0.35
HPGD P15428 2/20 0.35
POLB P06746 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK4 Q16654 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958239 0.77 LMNA (0.40) ALOX5KDM4EALDH1A1MEN1KMT2A
SCHEMBL13672076 0.76 KDM4E (0.38) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL30659408 0.76 PDK2 (0.38) KDM4EALDH1A1SMN1; SMN2BRD4CREBBP
SCHEMBL16792465 0.76 PDK2 (0.38) KDM4EALDH1A1SMN1; SMN2BRD4CREBBP
SCHEMBL3601425 0.76 PDK2 (0.38) KDM4EALDH1A1SMN1; SMN2BRD4MAPT
SCHEMBL4483899 0.76 PDK2 (0.38) KDM4EALDH1A1SMN1; SMN2BRD4CREBBP
SCHEMBL14444683 0.76 BRD4 (0.38) KDM4EALDH1A1SMN1; SMN2BRD4CREBBP
SCHEMBL10556439 0.74 ALOX5 (0.53) ALOX5KDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL21818563 0.74 ALOX5 (0.40) ALOX5KDM4EALDH1A1MEN1KMT2A
SCHEMBL4968292 0.73 DRD2 (0.36) KDM4EALDH1A1SMN1; SMN2BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001009127-A1 BENZOXAZINE DERIVATIVES AND THEIR THERAPEUTIC USE AVENTIS PHARMA S.A. (FR) 2001-02-08 WO disclosed